Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Larimar Therapeutics (LRMR) SEC Filings & 10K Form

Larimar Therapeutics logo
$3.82 +0.10 (+2.55%)
As of 10:38 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Larimar Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/14/2025
2:36 PM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2025
9:47 AM		JANUS HENDERSON GROUP PLC (Filed by)
Larimar Therapeutics, Inc. (Subject)
Larimar Therapeutics (Subject)
Form SCHEDULE 13G/A
08/14/2025
6:02 AM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2025
5:28 PM		Deerfield Healthcare Innovations Fund, L.P. (Reporting)
DEERFIELD MANAGEMENT COMPANY, L.P. (Reporting)
Deerfield Mgmt HIF, L.P. (Reporting)
Deerfield Mgmt III, L.P. (Reporting)
Deerfield Mgmt IV, L.P. (Reporting)
Deerfield Mgmt L.P. (Reporting)
DEERFIELD PARTNERS, L.P. (Reporting)
Deerfield Private Design Fund III, L.P. (Reporting)
Deerfield Private Design Fund IV, L.P. (Reporting)
Flynn James E (Reporting)
Larimar Therapeutics, Inc. (Issuer)
Larimar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025
5:26 PM		Flynn James E (Filed by)
Larimar Therapeutics, Inc. (Subject)
Larimar Therapeutics (Subject)
Form SCHEDULE 13D/A
07/30/2025
8:37 PM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form 424B5
07/31/2025
5:05 AM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
4:13 PM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2025
6:02 AM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
6:44 PM		DEERFIELD MANAGEMENT COMPANY, L.P. (0001009258) (Reporting)
Flynn James E (Reporting)
Larimar Therapeutics, Inc. (Issuer)
Larimar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
11:25 AM		JANUS HENDERSON GROUP PLC (Filed by)
Larimar Therapeutics, Inc. (Subject)
Larimar Therapeutics (Subject)
Form SCHEDULE 13G/A
05/13/2025
10:33 AM		GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Larimar Therapeutics, Inc. (Subject)
Larimar Therapeutics (Subject)
Form SCHEDULE 13G/A
05/05/2025
5:33 AM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
6:01 AM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
1:28 PM		BlackRock, Inc. (Filed by)
Larimar Therapeutics, Inc. (Subject)
Larimar Therapeutics (Subject)
Form SCHEDULE 13G/A
04/16/2025
4:11 PM		Larimar Therapeutics, Inc. (Subject)
Larimar Therapeutics (Subject)
Opaleye Management Inc. (Filed by)
Form SCHEDULE 13G
04/11/2025
6:42 AM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form DEF 14A
04/11/2025
6:45 AM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form ARS
03/24/2025
4:20 PM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/24/2025
6:03 AM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
3:15 PM		Celano Michael (Reporting)
Larimar Therapeutics, Inc. (Issuer)
Larimar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:15 PM		BEN-MAIMON CAROLE (Reporting)
Larimar Therapeutics, Inc. (Issuer)
Larimar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:16 PM		Clayton Russell (Reporting)
Larimar Therapeutics, Inc. (Issuer)
Larimar Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:16 PM		Larimar Therapeutics, Inc. (Issuer)
Larimar Therapeutics (Issuer)
Shankar Gopi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
6:22 AM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
10:49 AM		JANUS HENDERSON GROUP PLC (Filed by)
Larimar Therapeutics, Inc. (Subject)
Larimar Therapeutics (Subject)
Form SCHEDULE 13G/A
12/16/2024
6:02 AM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
6:02 AM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
10:41 AM		JANUS HENDERSON GROUP PLC (Filed by)
Larimar Therapeutics, Inc. (Subject)
Larimar Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:16 AM		Larimar Therapeutics, Inc. (Subject)
Larimar Therapeutics (Subject)
Verition Fund Management LLC (Filed by)
Form SC 13G/A
11/06/2024
1:29 PM		GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Larimar Therapeutics, Inc. (Subject)
Larimar Therapeutics (Subject)
Form SC 13G
10/30/2024
4:03 PM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
6:03 AM		Larimar Therapeutics, Inc. (Filer)
Larimar Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:LRMR) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...
Golden Portfolio | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsoredtc pixel
An $8 trillion-dollar discovery 17,000 ft underwater
A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...
Porter & Company | Sponsoredtc pixel
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsoredtc pixel
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...
Brownstone Research | Sponsoredtc pixel